Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

An Innovative Proprioceptive Instrument for Upper Extremities

18 août 2026 mis à jour par: National Cheng-Kung University Hospital

Development, Validation, and Clinical Application of an Innovative Proprioceptive Instrument for Upper Extremities: PropArm-PosiMoF (PropArm)

This study aimed to develop and validate an innovative proprioceptive assessment instrument for the upper extremities, the PropArm-PosiMoF (PropArm). This observational study was conducted in three stages. The first stage focused on the development and validation of PropArm, including test-retest reliability, concurrent validity, and convergent validity. The second stage established age norms and cut-off points in healthy adults. In the final stage, PropArm was applied to patients with proprioceptive impairments (stroke, shoulder impingement syndrome, and diabetes mellitus patients) to examine its diagnostic accuracy and clinical applicability.

Aperçu de l'étude

Type d'étude

Observationnel

Inscription (Estimé)

280

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte
  • Adulte plus âgé

Accepte les volontaires sains

Oui

Méthode d'échantillonnage

Échantillon non probabiliste

Population étudiée

The study population includes healthy young adults (20-29 yr), healthy adults (30-39, 40-49, and 50-59 yr), healthy older adults (60-69, 70-79, and 80-89 yr) across different age groups, and patients with stroke, shoulder impingement syndrome, or diabetes mellitus. Participants are right-hand dominant and able to follow verbal instructions without cognitive impairments.

La description

  1. Healthy Young Adults:

    Inclusion Criteria:

    • (1) Age between 20 and 29 years,
    • (2) Right-hand dominance, and
    • (3) Ability to understand three consecutive verbal instructions.

    Exclusion Criteria:

    • (1) Currently a student or faculty member of the Department of Occupational Therapy at National Cheng Kung University, or a staff member of the Department of Physical Medicine and Rehabilitation, National Cheng Kung University Hospital,
    • (2) History of surgery on the right upper limb,
    • (3) Presence of neuromusculoskeletal disorders that may affect sensory or motor function of the right upper limb, such as stroke or shoulder impingement syndrome, and
    • (4) Uncorrected hearing problems, such as hearing loss.
  2. Healthy Adults:

    Inclusion Criteria:

    • (1) Age between 30 to 39, 40 to 49, or 50 to 59 years,
    • (2) Right-hand dominance, and
    • (3) Ability to understand three consecutive verbal instructions.

    Exclusion Criteria:

    • (1) Currently a student or faculty member of the Department of Occupational Therapy at National Cheng Kung University, or a staff member of the Department of Physical Medicine and Rehabilitation, National Cheng Kung University Hospital,
    • (2) History of surgery on the right upper limb,
    • (3) Presence of neuromusculoskeletal disorders that may affect sensory or motor function of the right upper limb, such as stroke or shoulder impingement syndrome, and
    • (4) Uncorrected hearing problems, such as hearing loss.
  3. Healthy Older Adults:

    Inclusion Criteria:

    • (1) Age between 60 to 69, 70 to 79, or 80 to 89 years,
    • (2) Right-hand dominance, and
    • (3) Ability to understand three consecutive verbal instructions.

    Exclusion Criteria:

    • (1) Score below the 5th percentile on the Color Trails Test-Chinese Version (CTT-C),
    • (2) Currently a student or faculty member of the Department of Occupational Therapy at National Cheng Kung University, or a staff member of the Department of Physical Medicine and Rehabilitation, National Cheng Kung University Hospital,
    • (3) History of surgery on the right upper limb,
    • (4) Presence of neuromusculoskeletal disorders that may affect sensory or motor function of the right upper limb, such as stroke or shoulder impingement syndrome, and
    • (5) Uncorrected hearing problems, such as hearing loss.
  4. Stroke:

    Inclusion Criteria:

    • (1) Age between 20 and 89 years,
    • (2) Right-hemispheric hemorrhagic or ischemic stroke with lesions involving proprioceptive pathways or the primary somatosensory cortex, potentially resulting in difficulties with body position, movement, or force perception, or with fine tactile perception (e.g., localization, two-point discrimination, object recognition),
    • (3) Right-hand dominance, and
    • (4) Ability to understand three consecutive verbal instructions.

    Exclusion Criteria:

    • (1) Score below the 5th percentile on the Color Trails Test-Chinese Version (CTT-C),
    • (2) Upper limb still in acute pain stage,
    • (3) Muscle tone severe enough to affect right upper limb movement (e.g., score ≥ 1+ on the Modified Ashworth Scale),
    • (4) Uncorrected hearing problems, such as hearing loss.
  5. Shoulder Impingement Syndrome:

    Inclusion Criteria:

    • (1) Age between 20 and 89 years,
    • (2) Diagnosis of shoulder impingement syndrome in the right upper limb,
    • (3) Right-hand dominance, and
    • (4) Ability to understand three consecutive verbal instructions.

    Exclusion Criteria:

    • (1) Score below the 5th percentile on the Color Trails Test-Chinese Version (CTT-C),
    • (2) Upper limb still in acute pain stage,
    • (3) Uncorrected hearing problems, such as hearing loss.
  6. Diabetes (DM):

Inclusion Criteria:

  • (1) Age between 20 and 89 years,
  • (2) Diagnosis of diabetes mellitus by a specialist physician, based on one of the following:

    1. Fasting plasma glucose (FPG) ≥ 126 mg/dL or 7.0 mmol/L;
    2. Hemoglobin A1C (HbA1c) ≥ 6.5%;
    3. Plasma glucose ≥ 200 mg/dL or 11.1 mmol/L at 2 hours during an oral glucose tolerance test (OGTT);
    4. Presence of hyperglycemia symptoms (polyphagia, polyuria, polydipsia, and unexplained weight loss) with a random plasma glucose ≥ 200 mg/dL.

Diagnosis of diabetes is confirmed if any two of items (a-c) are met, or if any one of them remains positive on repeat testing; fulfillment of item (d) alone is also sufficient for diagnosis.

  • (3) Right-hand dominance, and
  • (4) Ability to understand three consecutive verbal instructions.

Exclusion Criteria:

  • (1) Score below the 5th percentile on the Color Trails Test-Chinese Version (CTT-C),
  • (2) History of surgery on the right upper limb,
  • (3) Presence of other neuromusculoskeletal disorders that may affect sensory or motor function of the right upper limb, and
  • (4) Current skin infection, and
  • (5) Uncorrected hearing problems, such as hearing loss.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

Cohortes et interventions

Groupe / Cohorte
Healthy Young Adults
20-29 years-old
Healthy Adults
30-59 years-old
Healthy Older Adults
60-89 years-old
Stroke
20-89 year-old
Shoulder Impingement Syndrome
20-89 year-old
Diabetes (DM)
20-89 years-old

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
PropArm-PosiMoF (PropArm) - Healthy Young Adult Group - Baseline, within 2 weeks after Baseline
Délai: Baseline, within 2 weeks after Baseline
The instrument is designed to measure proprioception by recording position and force data. In the first stage, PropArm was conducted twice to examine the test-retest reliability of healthy young adults. In other stages, PropArm were collected once.
Baseline, within 2 weeks after Baseline
PropArm-PosiMoF (PropArm) - Healthy Adult Group - Baseline
Délai: Baseline
The instrument is designed to measure proprioception by recording position and force data. In the first stage, PropArm was conducted twice to examine the test-retest reliability of healthy young adults. In other stages, PropArm were collected once.
Baseline
PropArm-PosiMoF (PropArm) - Stroke Group - Baseline
Délai: Baseline
The instrument is designed to measure proprioception by recording position and force data. In the first stage, PropArm was conducted twice to examine the test-retest reliability of healthy young adults. In other stages, PropArm were collected once.
Baseline
PropArm-PosiMoF (PropArm) - Shoulder Impingement Syndrome Group - Baseline
Délai: Baseline
The instrument is designed to measure proprioception by recording position and force data. In the first stage, PropArm was conducted twice to examine the test-retest reliability of healthy young adults. In other stages, PropArm were collected once.
Baseline
PropArm-PosiMoF (PropArm) - Diabetes Mellitus Group - Baseline
Délai: Baseline
The instrument is designed to measure proprioception by recording position and force data. In the first stage, PropArm was conducted twice to examine the test-retest reliability of healthy young adults. In other stages, PropArm were collected once.
Baseline
MicroFET3 Hand-held Dynamometer (MicroFET3) - Healthy Young Adult Group - Baseline, within 2 weeks after Baseline
Délai: Baseline, within 2 weeks after Baseline
The MicroFET3 is used to quantify the muscle power of elbow.
Baseline, within 2 weeks after Baseline
MicroFET3 Hand-held Dynamometer (MicroFET3) - Healthy Adult Group - Baseline
Délai: Baseline
The MicroFET3 is used to quantify the muscle power of elbow.
Baseline
MicroFET3 Hand-held Dynamometer (MicroFET3) - Stroke Group - Baseline
Délai: Baseline
The MicroFET3 is used to quantify the muscle power of elbow.
Baseline
MicroFET3 Hand-held Dynamometer (MicroFET3) - Shoulder Impingement Syndrome Group - Baseline
Délai: Baseline
The MicroFET3 is used to quantify the muscle power of elbow
Baseline
MicroFET3 Hand-held Dynamometer (MicroFET3) - Diabetes Mellitus Group - Baseline
Délai: Baseline
The MicroFET3 is used to quantify the muscle power of elbow.
Baseline
VICON Motion Capture System (VICON) - Healthy Young Adult Group - Baseline
Délai: Baseline
VICON is used to capture the position data of limbs in space.
Baseline
Manual Tactile Test-Barognosis (MTT-B) - Healthy Young Adult Group - Baseline, within 2 weeks after Baseline
Délai: Baseline, within 2 weeks after Baseline
The MTT-B is used to assess the ability to discriminate objects without vision (barognosis sense) of hand.
Baseline, within 2 weeks after Baseline
Manual Tactile Test-Barognosis (MTT-B) - Healthy Adult Group - Baseline
Délai: Baseline
The MTT-B is used to assess the ability to discriminate objects without vision (barognosis sense) of hand.
Baseline
Manual Tactile Test-Barognosis (MTT-B) - Stroke Group - Baseline
Délai: Baseline
The MTT-B is used to assess the ability to discriminate objects without vision (barognosis sense) of hand.
Baseline
Manual Tactile Test-Barognosis (MTT-B) - Shoulder Impingement Syndrome Group - Baseline
Délai: Baseline
The MTT-B is used to assess the ability to discriminate objects without vision (barognosis sense) of hand.
Baseline
Manual Tactile Test-Barognosis (MTT-B) - Diabetes Mellitus Group - Baseline
Délai: Baseline
The MTT-B is used to assess the ability to discriminate objects without vision (barognosis sense) of hand.
Baseline

Autres mesures de résultats

Mesure des résultats
Description de la mesure
Délai
Color Trails Test-Chinese Version (CTT-C) - Healthy Adult Group those who over 60 years-old - Baseline
Délai: Baseline
The CTT-C is a screening test used to exclude potential mild cognitive impairment patients.
Baseline
Color Trails Test-Chinese Version (CTT-C) - Stroke Group those who over 60 years-old - Baseline
Délai: Baseline
The CTT-C is a screening test used to exclude potential mild cognitive impairment patients.
Baseline
Color Trails Test-Chinese Version (CTT-C) - Shoulder Impingement Syndrome Group those who over 60 years-old - Baseline
Délai: Baseline
The CTT-C is a screening test used to exclude potential mild cognitive impairment patients.
Baseline
Color Trails Test-Chinese Version (CTT-C) -Diabetes Mellitus Group those who over 60 years-old - Baseline
Délai: Baseline
The CTT-C is a screening test used to exclude potential mild cognitive impairment patients.
Baseline
Fugl-Meyer Assessment-Upper Extremity (FMA-UE) - Stroke Group - Baseline
Délai: Baseline
The FMA-UE is used to measure the motor function of affected hand in stroke patients.
Baseline
Goniometer Shoulder Range of Motion - Shoulder Impingement Syndrome Group - Baseline
Délai: Baseline
The goniometer is used to measure the range of motion (ROM) of both sides of shoulders.
Baseline

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

1 septembre 2026

Achèvement primaire (Estimé)

31 décembre 2027

Achèvement de l'étude (Estimé)

31 décembre 2027

Dates d'inscription aux études

Première soumission

17 juillet 2026

Première soumission répondant aux critères de contrôle qualité

18 août 2026

Première publication (Réel)

21 août 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

21 août 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

18 août 2026

Dernière vérification

1 février 2026

Plus d'information

Termes liés à cette étude

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner